European regulators approve J&J’s prostate cancer drug
Johnson & Johnson announced that the company’s investigational drug Zytiga (abiraterone acetate) has been approved by the European regulators. Zytiga
Read moreJohnson & Johnson
J&J’s Remicade Backed by FDA Committee for Approval in Pediatrics
Earlier on Thursday, Johnson & Johnson’s Remicade (infliximab), which is administered to pediatric patients with moderately to severely active ulcerative
Read more